| Literature DB >> 18989755 |
Julie A Panepinto1, Nicholas M Pajewski, Lisa M Foerster, Svapna Sabnis, Raymond G Hoffmann.
Abstract
PURPOSE: The objective of this study was to determine the impact of family income and sickle cell disease on the health-related quality of life (HRQL) of children.Entities:
Mesh:
Year: 2008 PMID: 18989755 PMCID: PMC2840660 DOI: 10.1007/s11136-008-9412-8
Source DB: PubMed Journal: Qual Life Res ISSN: 0962-9343 Impact factor: 4.147
Fig. 1Description of the available PedsQL parent-proxy reports and child self-reports for children with sickle cell disease (SCD) and control populations
Sociodemographic characteristics of the disease and control children
| Variable | Children with sickle cell disease | Children without sickle cell disease |
|
|---|---|---|---|
| Parent-proxy report total sample | |||
|
| 104 | 74 | – |
| Age (years) | 0.036 | ||
| 2–4 | 27 (26.0) | 26 (35.1) | |
| 5–7 | 14 (13.5) | 15 (20.3) | |
| 8–12 | 26 (25.0) | 21 (28.4) | |
| 13–18 | 37 (35.6) | 12 (16.2) | |
| Gender | 0.374 | ||
| Male | 52 (50.0) | 32 (43.2) | |
| Race/ethnicity | <0.001 | ||
| African American | 98 (94.2) | 58 (78.4) | |
| Other | 1 (1.0) | 14 (18.9) | |
| Unreported | 5 (4.8) | 2 (2.7) | |
| Disease status | – | ||
| Mild disease | 50 (48.1) | – | |
| Severe disease | 54 (51.9) | – | |
| Parent-reported family income level | 0.016 | ||
| >$40,000 | 22 (21.2) | 5 (6.8) | |
| >$20,000 and ≤$40,000 | 26 (25.0) | 13 (17.6) | |
| ≤$20,000 | 36 (34.6) | 35 (47.3) | |
| Unknown | 20 (19.2) | 21 (28.4) | |
| Median census household income | |||
| Mean ± SD | 28,678 ± 1,143 | 27,798 ± 1,557 | 0.253* |
| Child self-report total sample | |||
|
| 69 | 40 | – |
| Disease status | – | ||
| Mild disease | 26 (37.7) | – | |
| Severe disease | 43 (62.3) | – | |
| Parent-reported family income level | 0.037 | ||
| >$40,000 | 18 (26.1) | 2 (5.0) | |
| >$20,000 and ≤$40,000 | 19 (27.5) | 9 (22.5) | |
| ≤$20,000 | 21 (30.4) | 16 (40.0) | |
| Unknown | 11 (15.9) | 13 (32.5) | |
* P-value based on the Wilcoxon rank-sum test
Medical and neurobehavioral co-morbidities of disease and control children
| Sickle cell disease | Controls |
| |
|---|---|---|---|
|
| |||
| Any | 27 (26.0) | 35 (47.3) | 0.003 |
| Asthma | 20 (19.2) | 28 (37.8) | |
| Chronic allergies | 6 (5.8) | 11 (14.9) | |
| Diabetes | 1 (1.0) | 1 (1.4) | |
| Chronic orthopedic, bone, or joint problems | 9 (8.7) | 3 (4.1) | |
| Epilepsy | 4 (3.9) | 1 (1.4) | |
| Rheumatic disease | 1 (1.0) | 0 (0.0) | |
| Other | 2 (1.9) | 5 (6.8) | |
|
| |||
| Any | 42 (40.4) | 35 (47.3) | 0.359 |
| Anxiety problems | 6 (5.8) | 9 (12.2) | |
| Attentional problems | 24 (23.1) | 18 (24.3) | |
| Behavioral problems | 20 (19.2) | 18 (24.3) | |
| Depression | 8 (7.7) | 6 (8.1) | |
| Developmental delay or mental retardation | 4 (3.9) | 7 (9.5) | |
| Learning problems | 21 (20.1) | 14 (18.9) | |
| Speech problems | 10 (9.6) | 10 (13.5) | |
Ordinal logistic regression for PedsQL parent-proxy report
| Outcome | Total score | Physical health | Psychosocial health | |||
|---|---|---|---|---|---|---|
| OR* | 95% CI | OR* | 95% CI | OR* | 95% CI | |
| Age (years) | ||||||
| 2–4 (referent) | – | – | – | – | – | – |
| 5–7 | 1.85 | (0.75, 4.75) | 1.69 | (0.68, 4.19) | 1.51 | (0.62, 3.69) |
| 8–12 |
|
|
|
|
|
|
| 13–18 |
|
|
|
|
|
|
| Sickle cell disease | ||||||
| No disease (referent) | – | – | – | – | – | – |
| Mild sickle cell disease | 2.11 | (1.00, 4.43) |
|
|
|
|
| Severe sickle cell disease |
|
|
|
|
|
|
| Family income | ||||||
| >$40,000 (referent) | – | – | – | – | – | – |
| >$20,000 and ≤$40,000 | 1.69 | (0.72, 3.96) |
|
| 1.37 | (0.59, 3.19) |
| ≤$20,000 |
|
|
|
| 2.20 | (0.94, 5.15) |
| Medical co-morbidity |
|
|
|
|
|
|
| Neurobehavioral co-morbidity |
|
| 1.34 | (0.73, 2.46) |
|
|
OR odds ratio, CI confidence interval
* The odds ratios denote the odds of scoring lower on the ordinal scale, i.e., the odds of having worse HRQL
Bold denotes statistical significance
Ordinal logistic regression for PedsQL child-self-report
| Outcome | Total score | Physical health | Psychosocial health | |||
|---|---|---|---|---|---|---|
| OR* | 95% CI | OR* | 95% CI | OR* | 95% CI | |
| Age (years) | ||||||
| 5–7 (referent) | – | – | – | – | – | – |
| 8–12 | 0.41 | (0.16, 1.03) | 0.63 | (0.25, 1.60) | 0.41 | (0.15, 1.07) |
| 13–18 | 0.43 | (0.17, 1.12) | 0.60 | (0.23, 1.53) | 0.38 | (0.15, 1.00) |
| Sickle cell disease | ||||||
| No disease (referent) | – | – | – | – | – | – |
| Mild sickle cell disease | 1.99 | (0.77, 5.15) | 2.59 | (0.98, 6.84) | 1.15 | (0.42, 3.14) |
| Severe sickle cell disease | 2.18 | (0.95, 4.99) |
|
| 1.80 | (0.78, 4.18) |
| Income level | ||||||
| >$40,000 (referent) | – | – | – | – | – | – |
| >$20,000 and ≤$40,000 | 2.07 | (0.74, 5.78) | 1.70 | (0.60, 4.78) | 1.95 | (0.68, 5.59) |
| ≤$20,000 | 2.01 | (0.72, 5.64) | 1.62 | (0.58, 4.54) | 1.54 | (0.53, 4.53) |
| Medical co-morbidity | 1.58 | (0.77, 3.25) | 1.19 | (0.57, 2.49) | 1.73 | (0.82, 3.65) |
| Neurobehavioral co-morbidity | 1.52 | (0.75, 3.09) | 1.24 | (0.60, 2.56) | 1.39 | (0.68, 2.83) |
Results based on n = 109; see Fig. 1
OR odds ratio, CI confidence interval
* The odds ratios denote the odds of scoring lower on the ordinal HRQL scale, i.e., the odds of having worse HRQL
Bold denotes statistical significance
Fig. 2Nomogram for the predicted probability (which denotes the probability that physical health-related quality of life (HRQL) is ≤1 SD below the population mean reported by Varni et al. [9]) of impaired physical HRQL: parent-proxy report